We previously established that increased intracellular cholesterol activates PERK/ATF4/KLF4 signaling and is responsible for a component of atherosclerosis-associated phenotypic modulation of SMCs (5, 6, 11). This evidence concerns the gene KLF4 and atherosclerosis.